HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.

Abstract
Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that in end-stage renal disease is markedly increased in serum; however, the mechanisms responsible for this increase are unclear. Here, we tested whether phosphate retention in chronic kidney disease (CKD) is responsible for the elevation of FGF23 in serum using Col4α3 knockout mice, a murine model of Alport disease exhibiting CKD. We found a significant elevation in serum FGF23 in progressively azotemic 8- and 12-week-old CKD mice along with an increased fractional excretion of phosphorus. Both moderate and severe phosphate restriction reduced fractional excretion of phosphorus by 8 weeks, yet serum FGF23 levels remained strikingly elevated. By 12 weeks, FGF23 levels were further increased with moderate phosphate restriction, while severe phosphate restriction led to severe bone mineralization defects and decreased FGF23 production in bone. CKD mice on a control diet had low serum 1,25-dihydroxyvitamin D (1,25(OH)(2)D) levels and 3-fold higher renal Cyp24α1 gene expression compared to wild-type mice. Severe phosphate restriction increased 1,25(OH)(2)D levels in CKD mice by 8 weeks and lowered renal Cyp24α1 gene expression despite persistently elevated serum FGF23. Renal klotho gene expression declined in CKD mice on a control diet, but improved with severe phosphate restriction. Thus, dietary phosphate restriction reduces the fractional excretion of phosphorus independent of serum FGF23 levels in mice with CKD.
AuthorsShiqin Zhang, Ryan Gillihan, Nan He, Timothy Fields, Shiguang Liu, Troy Green, Jason R Stubbs
JournalKidney international (Kidney Int) Vol. 84 Issue 4 Pg. 713-21 (Oct 2013) ISSN: 1523-1755 [Electronic] United States
PMID23698235 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Autoantigens
  • Collagen Type IV
  • Fgf23 protein, mouse
  • Phosphates
  • type IV collagen alpha3 chain
  • Vitamin D
  • Fibroblast Growth Factors
  • 1,25-dihydroxyvitamin D
  • Fibroblast Growth Factor-23
  • Steroid Hydroxylases
  • Vitamin D3 24-Hydroxylase
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
  • Glucuronidase
  • Klotho Proteins
Topics
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase (metabolism)
  • Administration, Oral
  • Animals
  • Autoantigens (genetics, metabolism)
  • Bone and Bones (metabolism)
  • Collagen Type IV (deficiency, genetics, metabolism)
  • Disease Models, Animal
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors (metabolism)
  • Glucuronidase (metabolism)
  • Hypophosphatemia, Familial (metabolism, prevention & control)
  • Kidney (metabolism)
  • Klotho Proteins
  • Male
  • Mice
  • Mice, Knockout
  • Nephritis, Hereditary (metabolism)
  • Phosphates (administration & dosage, deficiency, urine)
  • Renal Insufficiency, Chronic (metabolism)
  • Steroid Hydroxylases (metabolism)
  • Vitamin D (analogs & derivatives, blood)
  • Vitamin D3 24-Hydroxylase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: